Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Journal of Immunological Methods
|
December 21, 2000
Dendritic cell elimination as an assay of cytotoxic T lymphocyte activity in vivo
D S Ritchie, I F Hermans, J M Lumsden, et al.
Internal Medicine Journal
|
July 1, 2008
Diagnostic and therapeutic approach to persistent or recurrent fevers of unknown origin in adult stem cell transplantation and haematological malignancy
C O Morrissey, P G Bardy, M A Slavin, et al.
Bone Marrow Transplantation
|
August 4, 2012
Pegfilgrastim compared with filgrastim for cytokine-alone mobilization of autologous haematopoietic stem and progenitor cells
K E Herbert, P Gambell, E K Link, et al.
Bone Marrow Transplantation
|
June 3, 2014
Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial
K E Herbert, L Demosthenous, G Wiesner, et al.
Gene Therapy
|
April 30, 2010
Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype
P Neeson, A Shin, K M Tainton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 15, 2018
Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity
A J Davenport, R S Cross, K A Watson, et al.
British Journal of Cancer
|
June 29, 2013
Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy
C Y Cheah, M S Hofman, M Dickinson, et al.
Gene Therapy
|
March 5, 2010
Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen
S Peinert, H M Prince, P M Guru, et al.
Clinical and Experimental Immunology
|
October 1, 2015
The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma
K Jones, L Wockner, R M Brennan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 26, 2013
Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network
C Y Cheah, A George, E Giné, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Journal of Immunological Methods
|
December 21, 2000
Dendritic cell elimination as an assay of cytotoxic T lymphocyte activity in vivo
D S Ritchie, I F Hermans, J M Lumsden, et al.
Internal Medicine Journal
|
July 1, 2008
Diagnostic and therapeutic approach to persistent or recurrent fevers of unknown origin in adult stem cell transplantation and haematological malignancy
C O Morrissey, P G Bardy, M A Slavin, et al.
Bone Marrow Transplantation
|
August 4, 2012
Pegfilgrastim compared with filgrastim for cytokine-alone mobilization of autologous haematopoietic stem and progenitor cells
K E Herbert, P Gambell, E K Link, et al.
Bone Marrow Transplantation
|
June 3, 2014
Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial
K E Herbert, L Demosthenous, G Wiesner, et al.
Gene Therapy
|
April 30, 2010
Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype
P Neeson, A Shin, K M Tainton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 15, 2018
Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity
A J Davenport, R S Cross, K A Watson, et al.
British Journal of Cancer
|
June 29, 2013
Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy
C Y Cheah, M S Hofman, M Dickinson, et al.
Gene Therapy
|
March 5, 2010
Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen
S Peinert, H M Prince, P M Guru, et al.
Clinical and Experimental Immunology
|
October 1, 2015
The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma
K Jones, L Wockner, R M Brennan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 26, 2013
Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network
C Y Cheah, A George, E Giné, et al.
Page
of 4